Engineered Mesoporous Silica-Based Core-Shell Nanoarchitectures for Synergistic Chemo-Photodynamic Therapies.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Combinatorial therapies offer synergistic effects for enhanced cancer treatment.
• Developing efficient drug delivery systems is crucial for multi-modal cancer therapy.

Purpose of the Study:

• To fabricate core-shell silica-mesoporous silica nanoparticle (MSN) architectures for synergistic photodynamic therapy (PDT), chemotherapy, and chemodynamic therapy (CDT).
• To investigate the potential of these nanoarchitectures in treating skin melanoma.

Main Methods:

• Fabrication of core (silica)-shell (MSNs) nanoarchitectures.
• Loading methylene blue (MB) in the silica core for PDT and doxorubicin (Dox) in MSNs for chemotherapy and CDT.
• Utilizing copper-ligand coordination for pH-sensitive Dox release and triggering Fenton-like reactions for CDT.

Main Results:

• Successful fabrication and characterization of the core-shell nanoarchitectures.
• Demonstrated synergistic anti-cancer efficacy against skin melanoma.
• MB facilitated singlet oxygen generation for PDT, while Dox and copper ions promoted CDT.

Conclusions:

• The developed MSNs-based core-shell nanoarchitectures show significant potential for synergistic cancer ablation.
• This multi-modal therapeutic strategy offers a promising approach for effective cancer treatment.